Gani, R., Griffin, J., Kelly, S. & Rutten-van Mölken, M.P.M.H. (2010).Economic analyses comparing tiotropium with ipratropium orsalmeterol in UK patients with COPD. Primary Care RespiratoryJournal, 19(1), 68-74.Gerhards, S.A.H., Graaf, L.E. de, Jacobs, L.E. de, Severens, J.L., Huibers,M.J.H., Arntz, A., Riper, H., Widdershoven, G., Metsemakers, J.F.M. &Evers, S.M.A.A. (2010). Economic evaluation of online computerisedcognitive-behavioural therapy without support for depression in primarycare: randomised trial. British Journal of Psychiatry, 196, 310-318.Goedhart, G., Wal, M., van der, Cuijpers, P. & Bonsel, G.J. (2009).Psychosocial problems and continued smoking during pregnancy.Addictive Behaviours, 34, 403-406.Goor, K.M., Sprundel, E. van, Lemij, H.G., Plochg, T., Klazinga, N.S. &Koopmanschap, M.A. (2010). Cost-effectiveness of monitoring glau comapatients in shared care: an economic evaluation alongside a randomizedcontrolled trial. Bmc Health Services Research, 10(312), 1-11.Goossens, L.M.A., Riemersma, R.A., Postma, D.S., Molen, T. van der &Rutten-van Mölken, M.P.M.H. (2009). An Economic Evaluation ofBudesonide/Formoterol for Maintenance and Retriever Treatment inAsthma in General Practice. Advances in Therapy, 26(9), 872-885.Goossens, L.M.A., Standaert, B., Hartwig, N.G., Hovels, A.M. & AL, M.J.(2009). Conclusions on cost-effectiveness of rotavirus vaccinationhighly dependent on assumptions. Vaccine, 27, 2531-2532.Graaf, G. de & Exel, N.J.A. van (2009). Using Q Methodology inAdministrative Ethics. Public Integrity, 11(1), 63-78.Grit, K.J. & Bont, A.A. de (2010). Tailor-made finance versus tailormadecare. Can the state strengthen consumer choice in healthcareby reforming the financial structure of long-term care? Journal ofMedical Ethics, 36, 79-83.Groenendijk, A.G., Birnie, E., Boeckxstaens, G.E., Roovers, J.P.W. &Bonsel, G.J. (2009). Anorectal Function Testing and AnalEndosonography in the Diagnostic Work-Up of Patients withPrimary Pelvic Organ Prolapse. Gynecologic & Obstetric Investigation,67, 187-194.Groenendijk, A.G., Birnie, E., Blok, S. de, Adriaanse, A.H., Ankum,W.M., Roovers, J.P.W. & Bonsel, G.J. (2009). Clinical-decision taking inprimary pelvic organ prolapse; the effects of diagnostic tests ontreatment selection in comparison with a consesus meeting.International Urogynecology Journal and Pelvic Floor Dysfunction, 20,711-719.Groot, C.A. de, Stupp, R. & Bent, M. van den (2009). Cost-effectivenessof temozolomide for the threatment of newly diagnosed glioblastomamultiforme. Expert review of pharmacoeconomics & outcomesresearch, 9(3), 235-241.74
Hakkaart-van Roijen, L., Verboom, P., Philips, R. & Al, M.J. (2009).The cost utility of solifenacin in the threatment of overactive bladder.International Urology and Nephrology, 41, 293-298.Heesch, M.M. van, Bonsel G.J., Dumoulin, J.C., Evers, J.L.H., HoevenM.A.H.B.M. van der, Severens J.L., Dykgraaf RH.M., Veen, F. van der,Tonch, N., Nelen, W.L.D.M., Zonneveld, P. van, Goudoever, J.B. van,Tamminga, P., Steiner, K., Koopman-Esseboom, C., Beijsterveldt,C.E. van, Boomsma, D.I., Snellen, D., Dirksen, C.D. (2010). Long termcosts and effects of reducing the number of twin pregnancies in IVFby single embryo transfer: the TwinSing study. BMG Pediatrics, 10(75),1-11.Hendrix, A., Werf, C. van der, Bots, M.L., Birnie, E., Smagt, J.J. van der,Borleffs, C.J.W., Vink, A., Weert, H.C. van, Doevendans, P.A.F.M., Wilde,A.A.M., Mosterd, A. & Langen, I.M. van (2010). Rationale and design ofthe CAREFUL study. Netherlands Heart Journal, 18(6), 286-290.Hendrix, M., Pavlova, M., Nieuwenhuijze, M.J., Severens, J.L. & Nijhuis,J.G. (2010). Differences in preferences for obstetric care betweennulliparae and their partners in the Netherlands: a descrete-choiceexperiment. Journal of Psychosomatic Obstetrics and Gynecology,31(4), 243-251.Herk-Sukel, M.P.P. van, Poll-Franse, L.V. van de, Voogd, A.C.,Nieuwenhuijzen, G.A.P., Coebergh, J.W.W. & Herings, R.M.C. (2010).Half of breast cancer patients discontinue tamoxifen and anyendocrine treatment before the end of the recommended treatmentperiod of 5 years: a population-based analysis. Breast Cancer Researchand Treatment, 122(3), 843-851.Herk-Sukel, M.P.P. van, Poll-Franse, L.V. van de, Lemmens, V.E.P.P.,Vreugdenhil, G., Pruijt, J.F.M., Coebergh, J.W.W. & Herings, R.M.C.(2010). New opportunities for drug outcomes research in cancerpatients: The linkage of the Eindhoven Cancer Registry and thePHARMO Record Linkage System. European Journal of Cancer, 46(2),395-404.Hoogendoorn, E.J.I., Wetering, C.R. van, Schols, A.M.W.J. & Rutten-vanMölken, M.P.M.H. (2009). Self-report versus care provider registrationof healthcare utilization: impact on cost and cost-utility. InternationalJournal of Technology Assessment in Health Care, 25(4), 588-595.Hoogendoorn, E.J.I., Feenstra, T.L., Hoogenveen, R.T. & Rutten-vanMölken, M.P.M.H. (2010). Association between lung function andexacerbation frequency in patients with COPD. International Journalof COPD, 5, 435-444.Hoogendoorn, E.J.I., Wetering, C.R. van, Schols, A.M.W.J. & Rutten-vanMölken, M.P.M.H. (2010). Is INTERdisciplinary COMmunity-based COPDmanagement (INTERCOM) cost-effective? European RespiratoryJournal, 35(1), 79-87.75
- Page 1:
Institute of Health Policy & Manage
- Page 4 and 5:
COLOPHONActivities report 2009-2010
- Page 6 and 7:
1Ambitious andcommittedProf. Wilfri
- Page 8 and 9:
- expressed in the CWTS score - is
- Page 10 and 11:
2ResearchProf. Erik Schut, PhD, dir
- Page 12 and 13:
health care domain in developing co
- Page 14 and 15:
Competition and regulationin health
- Page 16 and 17:
Research theme 1The introduction of
- Page 18 and 19:
Quality and efficiencyin health car
- Page 20 and 21:
Since its foundation in 1982, socio
- Page 22 and 23:
Management and organisationof healt
- Page 24:
INFORMATION AND COMMUNICATION TECHN
- Page 27 and 28: esources and costs. This standardis
- Page 29 and 30: Part of the HEFPA projectis, for ex
- Page 31 and 32: also see organisationssuch as Kaise
- Page 33 and 34: countries and Panama.Whereas in Eur
- Page 35 and 36: health care organisations. Managers
- Page 37 and 38: example, the education facilitating
- Page 39 and 40: This project will continuein 2011 u
- Page 41 and 42: Management. In 2009Trudie van Duin
- Page 43 and 44: students graduating isgood, but the
- Page 45 and 46: Course was organised forthe third t
- Page 47 and 48: Since 2009, the Academyprovides yea
- Page 49 and 50: developments in thecompensation sys
- Page 51 and 52: knowledge. Apart from the office ro
- Page 54 and 55: 5Facts and figuresEducation2008-200
- Page 56 and 57: 6StaffxxxRESEARCH GROUP HEALTH ECON
- Page 58 and 59: xxxRESEARCH GROUP HEALTHINSURANCERe
- Page 61 and 62: 7 AcademicPublicationsPlease turn t
- Page 63 and 64: WETENSCHAPPELIJK ARTIKEL / BRIEF AA
- Page 65 and 66: Exter, A.P. den (2010). Health Syst
- Page 67 and 68: Hermans, H.E.G.M. & Buijsen, M.A.J.
- Page 69 and 70: Noord, T.J.C. van (2010). Gezondhei
- Page 71 and 72: Al, M.J., Hakkaart-van Roijen, L.,
- Page 73 and 74: Boormans, E.M.A., Birnie, E., Oepke
- Page 75: Dror, D.M., Putten, O. van & Koren,
- Page 79 and 80: Kippersluis, J.L.W. van, O'Donnell,
- Page 81 and 82: Poel, E. van de & Speybroeck, N. (2
- Page 83 and 84: Tromp, M., Eijsden, M. van, Ravelli
- Page 85 and 86: Wyers, C.E., Breedveld, J.J.L., Rei
- Page 87 and 88: Zuiderent, T. & Berg, M. (2010). Th
- Page 89 and 90: Thunnissen, M.M., Duivenvoorden, H.
- Page 91 and 92: WETENSCHAPPELIJK ARTIKEL / BRIEF AA
- Page 93 and 94: Hasman, A., Andersen, S.K., Klein,
- Page 95 and 96: Pirnejad, H. (2009). Invited commen
- Page 97 and 98: Wijngaarden, J.D.H. van, Weggelaar-
- Page 99 and 100: Hout, E. van, Stibane, R., Frederik
- Page 101 and 102: Stoopendaal, A.M.V. (2009). De zorg
- Page 103 and 104: WORKING PAPERSWORKING PAPERSAttema,